VIEMED HEALTHCARE, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Viemed Healthcare, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
  • Viemed Healthcare, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1.59M, a 20.8% increase year-over-year.
  • Viemed Healthcare, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $4.48M, a 21.2% increase year-over-year.
  • Viemed Healthcare, Inc. annual Income Tax Expense (Benefit) for 2023 was $4.15M, a 49.9% increase from 2022.
  • Viemed Healthcare, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.77M, a 18% decline from 2021.
  • Viemed Healthcare, Inc. annual Income Tax Expense (Benefit) for 2021 was $3.38M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.48M $1.59M +$274K +20.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $4.21M $768K +$40K +5.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.17M $518K +$17K +3.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $4.15M $1.6M +$453K +39.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $3.7M $1.32M +$864K +189% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $2.83M $728K +$307K +72.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.52M $501K -$244K -32.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $2.77M $1.15M +$178K +18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $2.59M $456K -$930K -67.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $3.52M $421K -$825K -66.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.35M $745K +$968K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $3.38M $968K +$817K +541% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.56M $1.39M +$245K +21.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $2.32M $1.25M +$7.89M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$5.58M -$223K -$410K -219% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$5.17M $151K +$93K +160% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$5.26M $1.14M +$1.09M +2137% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$6.35M -$6.65M -$6.67M -27792% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $320K $187K +$49K +35.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $271K $58K -$69K -54.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $340K $51K +$16K +45.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $324K $24K +$24K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $300K $138K +$138K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $162K $127K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $35K Jul 1, 2018 Sep 30, 2018 10-K 2020-03-04
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-K 2020-03-04
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-K 2020-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.